OurProductBotulinumToxinTypeAforCosmeticTherapy MEDBTXInjectable MEDBTXisperfectlycompatiblewithallinjectableC.botulinumtoxinscurrentlyavailable.ThisallowsphysicianstouseMEDBTXTopicalUseVialtogetherwithanysuchtoxins,inslowandlowrespondingsubjects.TheuseofBTXATopicalUseVialHydraliftingistheidealtreatmentforusebetweeninjectiontreatments.Theversiondevisedformaintenancehastheexclusiveeffectofkeepingtheskinmoisturizedandtight.Itisavasoactiveflavonoid(escine)complexmainlyofvegetableoriginpreventingandenhancingcutaneoustelangiectasiascausedbymicrocirculationalterations.Itsactionreinforcescapillarywallsdecreasingseverityoferythrosis. HowtheProductisMade MEDBTXInjectable(BotulinumToxinTypeAfortherapy)isasterile,lyophilizedformofpurifiedC.botulinumtoxintypeA,producedfromthecrudetoxinofthecultureoftheHallstrainofClostridiumbotulinumgrowninamediumcontainingtrypticaseandyeastextract. Aseriesofpurifyingproceduresaretakentoformacrystallinecomplexconsistingoftheactivehighmolecularweighttoxinproteinand
BTXA( botulinum toxin typa a , remove wrinkles)